Program
VV261
A development code. Also written as “VV261 5mg group”, “VV261 600mg TID group” and “VV261 900mg TID group”.
Its studies are led by Vigonvita Life Sciences.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Vigonvita Life Sciences | 32 open or running | phase 1since Dec 11, 2025 | Dec 11, 2025 | Nov 30, 2026phase 1 · NCT07710326 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Dec 11, 2025First study: phase 1 study in Healthy VolunteersFirst studyNCT07302269 · 66 enrolled · China
- Jul 13, 2026Phase 1 study in Healthy VolunteersNCT07710326 · 16 planned · China
- Nov 4, 2026Phase 1 study in Severe Fever with Thrombocytopenia SyndromeNCT07927218 · 15 planned · China
Ahead
- Nov 30, 2026Primary completion: phase 1 study in Healthy VolunteersNCT07710326
- Dec 30, 2026Primary completion: phase 1 study in Severe Fever with Thrombocytopenia SyndromeNCT07927218
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07927218Severe Fever with Thrombocytopenia Syndrome · China | 1 | Not yet recruiting | Dec 30, 2026 | 15 |
| NCT07710326Healthy Volunteers · China | 1 | Recruiting | Nov 30, 2026 | 16 |
| NCT07302269Healthy Volunteers · China | 1 | Completed | Aug 19, 2026 | 66 |
How it is read
Names in the registry
- “VV261”, 3 entries
- “VV261 5mg group”, 1 entry
- “VV261 600mg TID group”, 1 entry
- “VV261 900mg TID group”, 1 entry
Codes read as this program: VV261.
Conditions, from the studies’ own filings
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.